From Medscape Ophthalmology

Coverage from the

American Society of Retina Specialists (ASRS) 2017 Annual Meeting

August 11 - 15, 2017; Boston, Massachusetts

August 11 - 15, 2017 Boston, Massachusetts

ASRS Progress in Diabetic Retinopathy in the Spotlight at ASRS Treatments for diabetic retinopathy with new mechanisms of action will be generating interest at the upcoming American Society of Retinal Specialists (ASRS) Annual Meeting.
Medscape Medical News, August 8, 2017

Conference News

ASRS Anti-VEGF Treatment May Not Stop Diabetic Retinopathy
Medscape Medical News, August 17, 2017
ASRS New Anti-VEGF Drug Promising for Wet Macular Degeneration
Medscape Medical News, August 15, 2017
ASRS Ophthalmologists Worry About Eclipse Viewing
Medscape Medical News, August 14, 2017

ASRS Real-World Anti-VEGF Results Fall Short in Macular Edema
Medscape Medical News, August 13, 2017
ASRS Progress in Diabetic Retinopathy in the Spotlight at ASRS
Medscape Medical News, August 8, 2017

Popular News From ASRS 2016

Financial Gains Taint Debate About Nutritional Supplements Charges of conflicts of interest have encumbered clinical decision-making after the Age-Related Eye Disease Study (AREDS) suggested nutritional supplements are beneficial in macular degeneration.
Medscape Medical News, Nov 14, 2016
Vancomycin in Cataract Procedures May Cause Blindness Researchers have documented 35 eyes with severe hemorrhagic occlusive retinal vasculitis after treatment with vancomycin during cataract procedures.
Medscape Medical News, Aug 15, 2016
Genes May Shape Supplements' Effect on Macular Degeneration Two new studies have reignited the controversy over the relationship of genes to the AREDS formulation of supplements being marketed to slow macular degeneration.
Medscape Medical News, Aug 10, 2016

Medscape Ophthalmology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Previous Coverage

Related Resource

AMD and Retinal Disease News & Perspectives